Source link : https://www.newshealth.biz/health-news/venetoclax-combo-safe-effective-in-aml-patients-age-80-and-up-real-world-data-show/
Venetoclax (Venclexta) combined with a hypomethylating agent (HMA) — the standard of care for older patients with acute myeloid leukemia (AML) — appeared to be safe and effective in patients in their 80s and 90s, a retrospective analysis showed. Median overall survival (OS) was 8.1 months among a total of 154 patients with a median […]
Author : News Health
Publish date : 2024-05-09 21:25:05
Copyright for syndicated content belongs to the linked Source.